In 98 HCC patients tested, 29 (29.6%) were HBeAg positive, 68 (69.4%) were anti-HBe positive and one (1%) was both HBeAg positive and anti-HBe positive. The gene discussed is HBE1; the disease is hepatocellular carcinoma.